Lonardi, S., Dasari, A., Tabernero, J., Garcia-Carbonero, R., Elez, E., Yoshino, T., Sobrero, A. F., Yao, J. C., García-Alfonso, P., Kocsis, J., Gracian, A. C., Sartore-Bianchi, A., Satoh, T., Randrian, V., Tomasek, J., Chong, G., Paulson, A. S., Wu, L., Chen, L. F., Eng, C. (2025). Overall survival with fruquintinib versus placebo after adjusting for subsequent anticancer therapy in patients with refractory metastatic colorectal cancer in the FRESCO-2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e15568